HY-2003
Moderate or Severe Submental Fullness
Sichuan Huiyu Pharmaceutical Co., LtdPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Moderate or Severe Submental Fullness cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Deoxycholic Acid Kythera Biopharmaceuticals | Phase 3 | BBB |
Loratadine Kythera Biopharmaceuticals | Phase 3 | BB |
LIDOCAINE Kythera Biopharmaceuticals | Phase 3 | BB |
Epinephrine Kythera Biopharmaceuticals | Phase 3 | BB |
IBUPROFEN Kythera Biopharmaceuticals | Phase 3 | BB |
Polyene Phosphatidylcholine AMIpharm Co., Ltd. | Phase 2 | B |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →